Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials.

Clark A, van Zandvoort K, Flasche S, Sanderson C, Bines J, Tate J, Parashar U, Jit M.

Lancet Infect Dis. 2019 Jun 6. pii: S1473-3099(19)30126-4. doi: 10.1016/S1473-3099(19)30126-4. [Epub ahead of print]

2.

Infant contact in day-care centres in Vietnam: A cross-sectional study to understand infant infection risk.

Toizumi M, Yoshida LM, Suzuki M, Nguyen HAT, Pinsent A, Dang DA, Flasche S.

Wellcome Open Res. 2019 May 1;4:75. doi: 10.12688/wellcomeopenres.15238.1. eCollection 2019.

3.

Sensitivity and negative predictive value for a rapid dengue test.

Flasche S, Smith PG.

Lancet Infect Dis. 2019 May;19(5):465-466. doi: 10.1016/S1473-3099(19)30167-7. No abstract available.

PMID:
31034385
4.

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya.

Ojal J, Griffiths U, Hammitt LL, Adetifa I, Akech D, Tabu C, Scott JAG, Flasche S.

Lancet Glob Health. 2019 May;7(5):e644-e654. doi: 10.1016/S2214-109X(18)30562-X.

5.

Within-host dynamics shape antibiotic resistance in commensal bacteria.

Davies NG, Flasche S, Jit M, Atkins KE.

Nat Ecol Evol. 2019 Mar;3(3):440-449. doi: 10.1038/s41559-018-0786-x. Epub 2019 Feb 11.

PMID:
30742105
6.

The role of pneumococcal conjugate vaccination in reducing pneumonia mortality.

Jit M, Flasche S.

Lancet Glob Health. 2019 Feb;7(2):e173-e174. doi: 10.1016/S2214-109X(18)30540-0. No abstract available.

7.

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis.

Chen C, Cervero Liceras F, Flasche S, Sidharta S, Yoong J, Sundaram N, Jit M.

Lancet Glob Health. 2019 Jan;7(1):e58-e67. doi: 10.1016/S2214-109X(18)30422-4.

8.

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.

Wilder-Smith A, Hombach J, Ferguson N, Selgelid M, O'Brien K, Vannice K, Barrett A, Ferdinand E, Flasche S, Guzman M, Novaes HM, Ng LC, Smith PG, Tharmaphornpilas P, Yoon IK, Cravioto A, Farrar J, Nolan TM.

Lancet Infect Dis. 2019 Jan;19(1):e31-e38. doi: 10.1016/S1473-3099(18)30494-8. Epub 2018 Sep 5. Review.

PMID:
30195995
9.

Seasonality of respiratory viruses causing hospitalizations for acute respiratory infections in children in Nha Trang, Vietnam.

Althouse BM, Flasche S, Minh LN, Thiem VD, Hashizume M, Ariyoshi K, Anh DD, Rodgers GL, Klugman KP, Hu H, Yoshida LM.

Int J Infect Dis. 2018 Oct;75:18-25. doi: 10.1016/j.ijid.2018.08.001. Epub 2018 Aug 14.

10.

Identifying human encounters that shape the transmission of Streptococcus pneumoniae and other acute respiratory infections.

le Polain de Waroux O, Flasche S, Kucharski AJ, Langendorf C, Ndazima D, Mwanga-Amumpaire J, Grais RF, Cohuet S, Edmunds WJ.

Epidemics. 2018 Dec;25:72-79. doi: 10.1016/j.epidem.2018.05.008. Epub 2018 May 19.

11.

Balancing Benefits and Risks of Antibiotic Use.

Flasche S, Atkins KE.

J Infect Dis. 2018 Sep 22;218(9):1351-1353. doi: 10.1093/infdis/jiy344. No abstract available.

PMID:
29873748
12.

Predicting the impact of pneumococcal conjugate vaccine programme options in Vietnam.

Le Polain De Waroux O, Edmunds WJ, Takahashi K, Ariyoshi K, Mulholland EK, Goldblatt D, Choi YH, Anh DD, Yoshida LM, Flasche S.

Hum Vaccin Immunother. 2018;14(8):1939-1947. doi: 10.1080/21645515.2018.1467201. Epub 2018 Jun 8.

13.

Characteristics of human encounters and social mixing patterns relevant to infectious diseases spread by close contact: a survey in Southwest Uganda.

le Polain de Waroux O, Cohuet S, Ndazima D, Kucharski AJ, Juan-Giner A, Flasche S, Tumwesigye E, Arinaitwe R, Mwanga-Amumpaire J, Boum Y 2nd, Nackers F, Checchi F, Grais RF, Edmunds WJ.

BMC Infect Dis. 2018 Apr 11;18(1):172. doi: 10.1186/s12879-018-3073-1.

14.

The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014.

Chan DYW, Edmunds WJ, Chan HL, Chan V, Lam YCK, Thomas SL, van Hoek AJ, Flasche S.

Epidemiol Infect. 2018 Apr;146(6):723-734. doi: 10.1017/S0950268818000444. Epub 2018 Mar 12.

15.

Vaccination to reduce antimicrobial resistance.

Atkins KE, Flasche S.

Lancet Glob Health. 2018 Mar;6(3):e252. doi: 10.1016/S2214-109X(18)30043-3. No abstract available.

16.

Social mixing in Fiji: Who-eats-with-whom contact patterns and the implications of age and ethnic heterogeneity for disease dynamics in the Pacific Islands.

Watson CH, Coriakula J, Ngoc DTT, Flasche S, Kucharski AJ, Lau CL, Thieu NTV, le Polain de Waroux O, Rawalai K, Van TT, Taufa M, Baker S, Nilles EJ, Kama M, Edmunds WJ.

PLoS One. 2017 Dec 6;12(12):e0186911. doi: 10.1371/journal.pone.0186911. eCollection 2017.

17.

Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination.

Masala GL, Lipsitch M, Bottomley C, Flasche S.

J R Soc Interface. 2017 Nov;14(136). pii: 20170620. doi: 10.1098/rsif.2017.0620.

18.

The scope for pneumococcal vaccines that do not prevent transmission.

Flasche S.

Vaccine. 2017 Oct 27;35(45):6043-6046. doi: 10.1016/j.vaccine.2017.09.073. Epub 2017 Oct 3.

19.

Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.

Ojal J, Flasche S, Hammitt LL, Akech D, Kiti MC, Kamau T, Adetifa I, Nurhonen M, Scott JAG, Auranen K.

Vaccine. 2017 Aug 16;35(35 Pt B):4561-4568. doi: 10.1016/j.vaccine.2017.07.019. Epub 2017 Jul 17.

20.

Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya.

Flasche S, Ojal J, Le Polain de Waroux O, Otiende M, O'Brien KL, Kiti M, Nokes DJ, Edmunds WJ, Scott JAG.

BMC Med. 2017 Jun 7;15(1):113. doi: 10.1186/s12916-017-0882-9.

21.

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.

Flasche S, Jit M, Rodríguez-Barraquer I, Coudeville L, Recker M, Koelle K, Milne G, Hladish TJ, Perkins TA, Cummings DA, Dorigatti I, Laydon DJ, España G, Kelso J, Longini I, Lourenco J, Pearson CA, Reiner RC, Mier-Y-Terán-Romero L, Vannice K, Ferguson N.

PLoS Med. 2016 Nov 29;13(11):e1002181. doi: 10.1371/journal.pmed.1002181. eCollection 2016 Nov.

22.

Using Pneumococcal Carriage Data to Monitor Postvaccination Changes in the Incidence of Pneumococcal Otitis Media.

Flasche S, Givon-Lavi N, Dagan R.

Am J Epidemiol. 2016 Nov 1;184(9):652-659. Epub 2016 Oct 15.

23.

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.

Penny MA, Verity R, Bever CA, Sauboin C, Galactionova K, Flasche S, White MT, Wenger EA, Van de Velde N, Pemberton-Ross P, Griffin JT, Smith TA, Eckhoff PA, Muhib F, Jit M, Ghani AC.

Lancet. 2016 Jan 23;387(10016):367-375. doi: 10.1016/S0140-6736(15)00725-4. Epub 2015 Nov 6.

24.

Ebola virus disease in the Democratic Republic of the Congo, 1976-2014.

Rosello A, Mossoko M, Flasche S, Van Hoek AJ, Mbala P, Camacho A, Funk S, Kucharski A, Ilunga BK, Edmunds WJ, Piot P, Baguelin M, Tamfum JJ.

Elife. 2015 Nov 3;4. pii: e09015. doi: 10.7554/eLife.09015.

25.

Measuring the impact of Ebola control measures in Sierra Leone.

Kucharski AJ, Camacho A, Flasche S, Glover RE, Edmunds WJ, Funk S.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14366-71. doi: 10.1073/pnas.1508814112. Epub 2015 Oct 12.

26.

Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.

Baguelin M, Camacho A, Flasche S, Edmunds WJ.

BMC Med. 2015 Oct 13;13:236. doi: 10.1186/s12916-015-0452-y.

27.

The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-regression Model.

Le Polain De Waroux O, Flasche S, Prieto-Merino D, Goldblatt D, Edmunds WJ.

Pediatr Infect Dis J. 2015 Aug;34(8):858-64. doi: 10.1097/INF.0000000000000717. Erratum in: Pediatr Infect Dis J. 2016 May;35(5):591.

28.

The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries.

Flasche S, Van Hoek AJ, Goldblatt D, Edmunds WJ, O'Brien KL, Scott JA, Miller E.

PLoS Med. 2015 Jun 9;12(6):e1001839. doi: 10.1371/journal.pmed.1001839. eCollection 2015 Jun. No abstract available.

29.

The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.

Flasche S, Le Polain de Waroux O, O'Brien KL, Edmunds WJ.

PLoS Comput Biol. 2015 Apr 16;11(4):e1004173. doi: 10.1371/journal.pcbi.1004173. eCollection 2015 Apr.

30.

Temporal Changes in Ebola Transmission in Sierra Leone and Implications for Control Requirements: a Real-time Modelling Study.

Camacho A, Kucharski A, Aki-Sawyerr Y, White MA, Flasche S, Baguelin M, Pollington T, Carney JR, Glover R, Smout E, Tiffany A, Edmunds WJ, Funk S.

PLoS Curr. 2015 Feb 10;7. pii: ecurrents.outbreaks.406ae55e83ec0b5193e30856b9235ed2. doi: 10.1371/currents.outbreaks.406ae55e83ec0b5193e30856b9235ed2.

31.

Evaluation of the benefits and risks of introducing Ebola community care centers, Sierra Leone.

Kucharski AJ, Camacho A, Checchi F, Waldman R, Grais RF, Cabrol JC, Briand S, Baguelin M, Flasche S, Funk S, Edmunds WJ.

Emerg Infect Dis. 2015 Mar;21(3):393-9. doi: 10.3201/eid2103.141892.

32.

Early indication for a reduced burden of radiologically confirmed pneumonia in children following the introduction of routine vaccination against Haemophilus influenzae type b in Nha Trang, Vietnam.

Flasche S, Takahashi K, Vu DT, Suzuki M, Nguyen TH, Le H, Hashizume M, Dang DA, Edmond K, Ariyoshi K, Mulholland EK, Edmunds WJ, Yoshida LM.

Vaccine. 2014 Dec 5;32(51):6963-6970. doi: 10.1016/j.vaccine.2014.10.055. Epub 2014 Nov 1.

33.

Airport screening for Ebola.

Mabey D, Flasche S, Edmunds WJ.

BMJ. 2014 Oct 14;349:g6202. doi: 10.1136/bmj.g6202. No abstract available.

34.

Age-dependent prevalence of nasopharyngeal carriage of streptococcus pneumoniae before conjugate vaccine introduction: a prediction model based on a meta-analysis.

Le Polain de Waroux O, Flasche S, Prieto-Merino D, Edmunds WJ.

PLoS One. 2014 Jan 23;9(1):e86136. doi: 10.1371/journal.pone.0086136. eCollection 2014.

35.

Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.

Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ.

PLoS Med. 2013 Oct;10(10):e1001527. doi: 10.1371/journal.pmed.1001527. Epub 2013 Oct 8.

36.

The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination.

Flasche S, Edmunds WJ, Miller E, Goldblatt D, Robertson C, Choi YH.

Proc Biol Sci. 2013 Oct 2;280(1771):20131939. doi: 10.1098/rspb.2013.1939. Print 2013 Nov 22.

37.

Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.

Lamb KE, Flasche S, Diggle M, Inverarity D, Greenhalgh D, Jefferies JM, Smith A, Edwards GF, Denham B, McMenamin J, McDonald E, Mitchell TJ, Clarke SC, Robertson C.

Vaccine. 2014 Jul 23;32(34):4356-63. doi: 10.1016/j.vaccine.2013.05.079. Epub 2013 Jun 24.

38.

Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and Wales.

Choi YH, Jit M, Flasche S, Gay N, Miller E.

PLoS One. 2012;7(7):e39927. doi: 10.1371/journal.pone.0039927. Epub 2012 Jul 13.

39.

Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations.

Weinberger DM, Harboe ZB, Flasche S, Scott JA, Lipsitch M.

Epidemiology. 2011 Mar;22(2):199-207. doi: 10.1097/EDE.0b013e3182087634.

40.

Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries.

Flasche S, Hens N, Boëlle PY, Mossong J, van Ballegooijen WM, Nunes B, Rizzo C, Popovici F, Santa-Olalla P, Hrubá F, Parmakova K, Baguelin M, van Hoek AJ, Desenclos JC, Bernillon P, Cámara AL, Wallinga J, Asikainen T, White PJ, Edmunds WJ.

Epidemics. 2011 Jun;3(2):125-33. doi: 10.1016/j.epidem.2011.03.005. Epub 2011 Apr 13.

42.

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, George R, Miller E.

PLoS Med. 2011 Apr;8(4):e1001017. doi: 10.1371/journal.pmed.1001017. Epub 2011 Apr 5.

43.

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ.

Vaccine. 2010 Mar 11;28(12):2370-84. doi: 10.1016/j.vaccine.2010.01.002. Epub 2010 Jan 21.

PMID:
20096762
44.

The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom.

Ghani A, Baguelin M, Griffin J, Flasche S, van Hoek AJ, Cauchemez S, Donnelly C, Robertson C, White M, Truscott J, Fraser C, Garske T, White P, Leach S, Hall I, Jenkins H, Ferguson N, Cooper B.

Version 2. PLoS Curr. 2009 Nov 16 [revised 2010 Jan 1];1:RRN1130. No abstract available.

45.

Can reactive school closures help critical care provision during the current influenza pandemic?

House T, Baguelin M, van Hoek AJ, Flasche S, White P, Sadique MZ, Eames K, Read J, Hens N, Melegaro A, Keeling M.

PLoS Curr. 2009 Oct 23;1:RRN1119.

Supplemental Content

Loading ...
Support Center